Streetbeat News

Products Services

ESPR

Esperion Therapeutics reported a 44% year-over-year growth in Q4 retail prescription equivalents and projects continued momentum in this segment into the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:06 am

BGNE

BeiGene, Ltd. announced FDA approval for a Biologics License Application for TEVIMBRA (tislelizumab) for first-line treatment of gastric or gastroesophageal junction cancers. The FDA's action date is expected in December 2024.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:02 am

RNLSY

The European auto industry, represented by the ACEA and led by Renault CEO Luca de Meo, has agreed not to contest the EU's decision to ban fossil-fuel vehicles by 2035. This decision is seen as a significant step towards the global transition to electric vehicles (EVs), despite challenges such as the need for more government subsidies and a widespread charging infrastructure. The industry's acceptance of the ban reflects a commitment to reducing reliance on fossil fuels, amidst slowing EV demand and competition from affordable Chinese models.

Portfolio Pulse from Benzinga Neuro

February 27, 2024 | 10:56 am

ARQT

Arcutis Biotherapeutics anticipates further reductions in R&D expenses in 2024, concentrating its investments on the commercial launches of Zoryve (Roflumilast) topical foam for treating seborrheic dermatitis.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:54 am

AES

AES Corp reported Q4 FY23 earnings with an adjusted EPS of $0.73, surpassing the consensus of $0.67, but missed revenue expectations with $2.97 billion against a forecast of $3.36 billion. The company saw a rise in non-regulated revenue and a decline in regulated revenue, with adjusted EBITDA also decreasing. AES exceeded its strategic objectives, including doubling renewables construction and securing significant asset sale proceeds. The company has a strong backlog and expects growth driven by renewables, U.S. utilities, and improved margins in Chile. AES raised its growth targets for adjusted EPS and EBITDA through 2027 and anticipates a dividend growth post-2024.

Portfolio Pulse from Lekha Gupta

February 27, 2024 | 10:52 am

LCID

Stifel lowered its price target on Lucid Group Inc (NASDAQ:LCID) from $5 to $4 but maintained a 'hold' rating, citing 'best-in-class' technology and potential positives like a lower-priced Lucid Air sedan and focus on cost control. Despite these positives and plans for the Gravity SUV production, concerns over cash burn prevent a 'buy' rating. Lucid reported a Q4 revenue miss and a loss of 29 cents per share, with total costs of $894 million. The company aims to produce 9,000 vehicles this year, up from 8,428 in 2023. Lucid shares closed up 4.3% on Monday and rose 1.59% in Tuesday's premarket, but are down 24.1% year-to-date.

Portfolio Pulse from Anan Ashraf

February 27, 2024 | 10:36 am

BTCUSD

El Salvador President Nayib Bukele, a proponent of Bitcoin, questioned the sustainability of the U.S. government's monetary policy, specifically its ability to print money indefinitely. During a speech at CPAC, he suggested that the U.S. finances itself through Treasury bonds bought by the Federal Reserve, which prints money for this purpose. Bukele argued that taxes are collected to maintain the illusion of public funding for the government. His comments come amid criticism of his governance and his support for Bitcoin as legal tender in El Salvador.

Portfolio Pulse from Benzinga Neuro

February 27, 2024 | 10:31 am

INFY

Infosys (NYSE:INFY) announced the launch of its Responsible AI Suite, part of Infosys Topaz, aimed at helping enterprises navigate the regulatory and ethical complexities of AI-powered transformation.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:12 am

BTCUSD

Trevor Noah expressed regret for not purchasing Bitcoin (BTC) during its early days when its price was significantly lower. Speaking at the Web Summit Qatar 2024, Noah highlighted his biggest mistake was not buying Bitcoin when it was 'nothing' and not taking the time to understand cryptocurrency. Bitcoin's value has recently reached $56,700, with its market capitalization surpassing $1.1 trillion, attributed to investments in Bitcoin-focused ETFs and excitement over the upcoming Bitcoin halving event.

Portfolio Pulse from Mehab Qureshi

February 27, 2024 | 10:10 am

META

Meta Platforms Inc. (NASDAQ:META) is set to unveil its first 'true' augmented reality (AR) glasses, codenamed Orion, at its Connect developer event this fall. The AR glasses, developed by Meta's Reality Labs division, aim to generate excitement in the high-tech wearables market. Although not immediately available for purchase, prototypes are being tested by select employees. This move comes as the smart glasses market grows, with Meta and competitors like Apple investing in AR and VR technologies.

Portfolio Pulse from Ananya Gairola

February 27, 2024 | 9:54 am